Related Experiment Video

Updated: Jan 25, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.4K

An Updated Review of Clostridium difficile Treatment in Pediatrics

Christopher T Campbell, Margaret Oates Poisson, Elizabeth Oates Hand

    The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
    |April 26, 2019
    PubMed

    Insights

    Clostridium difficile infection (CDI) in children poses challenges due to asymptomatic colonization. Recent guidelines offer updated pediatric-specific recommendations for managing this infection.

    Area of Science:

    • Infectious Diseases
    • Pediatric Medicine
    • Microbiology

    Background:

    • Clostridium difficile infection (CDI) presents significant clinical and economic burdens in healthcare.
    • Pediatric CDI cases are fewer but complicated by asymptomatic colonization in infants, impacting diagnosis.
    • Established treatments include metronidazole and oral vancomycin, with emerging options like fecal microbiota transplantation.

    Purpose of the Study:

    • To review risk factors, management, and prevention strategies for CDI in pediatric patients.
    • To discuss updated guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America specific to pediatric CDI.
    • To provide a comprehensive overview of current knowledge and recommendations for pediatric CDI.

    Main Methods:

    • Literature review of existing studies and clinical guidelines on pediatric CDI.
    • Analysis of epidemiological data and treatment outcomes for Clostridium difficile infection in children.
    • Synthesis of information regarding diagnostic challenges and therapeutic advancements.

    Main Results:

    • CDI screening and diagnosis in young children are complicated by high rates of asymptomatic colonization.
    • Metronidazole and oral vancomycin remain standard treatments, though newer agents show promise.
    • Updated guidelines now provide distinct recommendations for pediatric CDI management, differentiating from adult protocols.

    Conclusions:

    • Pediatric CDI requires tailored approaches due to unique epidemiological and physiological factors.
    • Emerging therapies and updated guidelines offer improved strategies for managing CDI in children.
    • Further research is needed to optimize prevention and treatment protocols for pediatric Clostridium difficile infection.

    Keywords:
    Clostridium difficileantibioticdiarrheapediatrics

    More Related Videos

    Culturing and Maintaining Clostridium difficile in an Anaerobic Environment11:13

    Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

    Published on: September 14, 2013

    40.0K
    Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R2029106:51

    Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

    Published on: December 10, 2016

    13.2K

    Related Concept Videos

    Review and Preview01:10

    Review and Preview

    In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
    Percentiles are a type of fractile that partition data into...
    8.3K
    Review and Preview01:13

    Review and Preview

    Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
    10.9K
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    214
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    276
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    200
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    261